Global Pharmaceutical Excipients Market

Pharmaceutical Excipients Market Size, Share, Growth Analysis, By Product Type (Organic Chemicals, Inorganic Chemicals, Others), By Functionality (Binders, Fillers/Diluents, Disintegrants, Coating Agents, Lubricants), By Formulation, By Source, By End User, By Region -Industry Forecast 2026-2033

Report ID: SQMIG35H2396 | Region: Global | Published Date: December, 2025
Pages: 175 |Tables: 155 |Figures: 71

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Pharmaceutical Excipients Market size was valued at USD 10.12 Billion in 2024 and is poised to grow from USD 10.81 Billion in 2025 to USD 18.29 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026–2033).

    The pharmaceutical excipients industry is moderately consolidated, with a mix of global chemical giants, specialized excipient manufacturers, and pharmaceutical solution providers competing for market share. Key players are focusing on expanding their product portfolios, enhancing manufacturing capabilities, and integrating advanced technologies to support the growing complexity of drug formulations. 'Glenmark Pharmaceuticals', 'Ichnos Sciences', 'Viatris Inc.', 'Idorsia Ltd.', 'BASF SE', 'Evonik Industries AG', 'Dow Inc.', 'Ashland Global Holdings Inc.', 'JRS Pharma', 'Colorcon, Inc.', 'Roquette Frères', 'CP Kelco', 'Signet Chemical Corporation'

    There is a rising focus on developing controlled-release and targeted drug delivery systems to enhance patient compliance and therapeutic efficacy. These formulations rely heavily on advanced excipients that can modulate the release profile of the active pharmaceutical ingredient (API), improve stability, and reduce dosing frequency. As chronic diseases and complex therapies increase globally, pharmaceutical companies are investing in excipients that support innovative delivery technologies such as sustained-release tablets, transdermal patches, and implantable devices.

    Adoption of Multifunctional and Co-Processed Excipients: To simplify formulation processes and improve product performance, pharmaceutical companies are increasingly using multifunctional excipients that combine properties such as binding, disintegration, and flowability. Co-processed excipients, which are combinations of two or more components physically blended at the microscopic level, provide enhanced mechanical strength and compressibility. These excipients reduce manufacturing steps, improve tablet uniformity, and support the development of complex dosage forms, reflecting a pharmaceutical excipients market trend toward efficiency and innovation.

    What factors drive the Pharmaceutical Excipients Market in North America?

    Related Reports

    Biopharmaceuticals Excipients Market
    Buy Now GET FREE SAMPLE
    Excipients Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Packaging Market
    Buy Now GET FREE SAMPLE
    Active Pharmaceutical Ingredients (API) Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Processing Equipment Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Processing and Packaging Equipment Market
    Buy Now GET FREE SAMPLE
    Sustained Release Excipients Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Manufacturing Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Pharmaceutical Excipients Market

    Report ID: SQMIG35H2396

    $5,300
    BUY NOW